ACE2 and COVID-19: The impact of cannabis smoke on SARS-CoV-2 infection and development of COVID-19 is not known, but experimental evidence suggests that CBD alone decreases ACE2 expression [177] and inhibits SARS-Cov-2 replication [178]; there is also evidence that CBD reduces COVID-19 related inflammation [179].